Viewing StudyNCT00114959



Ignite Creation Date: 2024-05-05 @ 11:43 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00114959
Status: TERMINATED
Last Update Posted: 2015-01-15
First Post: 2005-06-20

Brief Title: Homoharringtonine With Oral Gleevec in Chronic Accelerated and Blast Phase Chronic Myeloid Leukemia CML
Sponsor: ChemGenex Pharmaceuticals
Organization: Teva Branded Pharmaceutical Products RD Inc

Key Dates - Follows AllAPIJSON File Order

Start Date: 2005-10
Start Date Type: None
Primary Completion Date: 2008-06
Primary Completion Date Type: ACTUAL
Completion Date: 2009-03
Completion Date Type: ACTUAL
First Submit Date: 2005-06-20
First Submit QC Date: June 20 2005
Study First Post Date: 2005-06-21
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2015-01-15
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: 2012-05-03
Disp First Submit QC Date: May 3 2012
Disp First Post Date: 2012-05-08
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2015-01-08
Last Update Post Date: 2015-01-15
Last Update Post Date Type: ESTIMATED